Thermo Fisher Scientific Expands SARS-CoV-2 Testing Portfolio in India with Point-of-Care Testing Platform Kumar Jeetendra | June 16, 2021 Mumbai, India, June 15, 2021–Thermo Fisher Scientific today announced a introduction of the new and innovative SARS-CoV-2 Test that delivers gold-standard reverse transcription polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format. The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for …
